<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27217885</article-id>
      <article-id pub-id-type="pmc">4862789</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-23-60</article-id>
      <article-id pub-id-type="doi">10.11604/pamj.2016.23.60.8910</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hanane</surname>
            <given-names>Kloub</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salma</surname>
            <given-names>Benhmida</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khadija</surname>
            <given-names>Bellahammou</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ibrahim</surname>
            <given-names>Elghissassi</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saber</surname>
            <given-names>Boutayeb</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hind</surname>
            <given-names>M'rabti</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hassan</surname>
            <given-names>Errihani</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Kloub Hanane, Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>2</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>23</volume>
      <elocation-id>60</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Kloub Hanane et al.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Isolated peritoneal metastases of lung adenocarcinoma are very rare, even exceptional, occurring most often in the context of a multi-metastatic disease. This report presents a rare clinical case of isolated peritoneal metastasis from lung adenocarcinoma. We report a 56-year-old male who was monitored for lung adenocarcinoma whose evolution has been marked by an isolated metastatic recurrence in the peritoneum objectified by an abdominal-pelvic computed tomography (CT) and confirmed by a laparoscopy with abiopsy of the peritoneal nodules. The patient had received palliative chemotherapy with gemcitabine, cisplatin and bevacizumab. The evolution was marked by a progressive deterioration of the general condition and death two months after the third treatment cycle. Peritoneal carcinomatosis from lung adenocarcinoma is a very rare event, and is often associated with a poor prognosis.</p>
      </abstract>
      <kwd-group>
        <kwd>Lung cancer</kwd>
        <kwd>peritoneal carcinomatosis</kwd>
        <kwd>chemotherapy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Lung cancer is the world's most frequently diagnosed cancer (1.82 million) and the leading cause of cancer related death (1.6 million deaths) [<xref rid="CIT0001" ref-type="bibr">1</xref>]. Conventional metastatic sites are the liver, adrenal glands, the brain and bone. Isolated peritoneal metastasis is a very rare event. This report presents a rare clinical case of isolated peritoneal metastasis from lung adenocarcinoma.</p>
    </sec>
    <sec id="S0002">
      <title>Patient and observation</title>
      <p>A 56-year old male, with history of chronic smoking, was monitored from 2011 for a lung adenocarcinoma, initially classified as stage IIIA (pT2N3M0). The patient underwent a right upper lobectomy with lymph node dissection in January 2011. Adjuvant chemotherapy with paclitaxel and carboplatin was administered in 4 cycles until June 2011. In March 2012, he had abdominal pain. The abdominal-pelvic ultrasound showed small amounts of ascites. The hepatitis B and C serologies were normal, liver function tests and blood counts were normal. The chest and abdominal-pelvic computed tomography (CT) showed the presence of a moderate amount of ascites without obvious signs of lung relapse or abdominal visceral disease. Bone scan and brain CT were both normal. An ultrasound-guided puncture was attempted twice without success. The patient underwent exploratory laparoscopy which showed nodules of peritoneal carcinomatosis with a moderate amount of ascites. A biopsy of the peritoneal nodules was performed. The histological examination revealed adenocarcinoma. The immunohistochemistry showed that the carcinoma cells were positive for cytokeratin 7 (CK7) (<xref ref-type="fig" rid="F0001">Figure 1</xref>) and thyroid transcription factor-1 (TT1) (<xref ref-type="fig" rid="F0002">Figure 2</xref>) and negative for cytokeratin 20 (CK20) (<xref ref-type="fig" rid="F0003">Figure 3</xref>). Those immunohistological findings suggested the tumor to be metastatic from the primary lung adenocarcinoma. Genotyping of epidermal growth factor receptor (EGFR) exons 18 to 21 did not show any detectable mutation. The patient underwent palliative chemotherapy following the gemcitabine, cisplatin and bevacizumab protocol. The evolution was marked by a progressive deterioration of the general condition and death two months after the third treatment cycle.</p>
      <fig id="F0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Biopsy of the peritoneal nodules shows positive staining CK7 on immunohistochemistry</p>
        </caption>
        <graphic xlink:href="PAMJ-23-60-g001"/>
      </fig>
      <fig id="F0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Biopsy of the peritoneal nodules shows positive staining TTF1 on immunohistochemistry</p>
        </caption>
        <graphic xlink:href="PAMJ-23-60-g002"/>
      </fig>
      <fig id="F0003" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Biopsy of the peritoneal nodules: CK20 negative on immunohistochemistry</p>
        </caption>
        <graphic xlink:href="PAMJ-23-60-g003"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="S0003">
      <title>Discussion</title>
      <p>Preferential metastases sites for lung cancer are the liver, adrenal glands, the brain and bone. While abdominal visceral metastases have been reported in the context of lung cancer [<xref rid="CIT0002" ref-type="bibr">2</xref>&#x2013;<xref rid="CIT0004" ref-type="bibr">4</xref>], isolated peritoneal metastasis is a very rare event, most often described in old autopsy series [<xref rid="CIT0005" ref-type="bibr">5</xref>]. It can occur in the context of a multi-organ metastasis and is only exceptionally indicative of a primary lung tumor. Satoh et al reviewed the observations of 1041 patients treated consecutively between 1976 and 2001; 12 patients (1.2%) developed peritoneal involvement over the course of the disease. Six and nine of the twelve patients had abdominal visceral metastases and pleural metastasis, respectively [<xref rid="CIT0006" ref-type="bibr">6</xref>]. The frequency of the peritoneal metastasis was higher in the case of adenocarcinoma and large cell carcinoma. Other cases of peritoneal carcinomatosis of lung cancer have been reported in the literature but the majority of patients had advanced disease with multiple metastatic sites [<xref rid="CIT0007" ref-type="bibr">7</xref>]. The tumors that most often accompany peritoneal disease are those of the ovary and the gastrointestinal tract [<xref rid="CIT0008" ref-type="bibr">8</xref>]. Three implantation mechanisms of the tumor cells on the peritoneum have been described in the literature [<xref rid="CIT0009" ref-type="bibr">9</xref>]; by contiguity expansion secondary to the involvement of the serosa and its supersession by the tumor resulting in exfoliation of tumor cells in the peritoneal cavity, where they are likely to take hold; iatrogenic expansion which may be secondary to the direct trauma of the tumor during its removal from where tumor cells circulate in the veins and lymph nodes severed during removal of the tumor. Systemic expansion is rare and can occur for a number of digestive and non-digestive cancers but at an advanced stage of development (breast, lungs, etc.). However, the mechanism of the isolated peritoneal dissemination of a lung cancer has not been studied [<xref rid="CIT0006" ref-type="bibr">6</xref>]. Clinically, peritoneal carcinomatosis is usually asymptomatic at the early stage, making its detection less likely. In recent years, with the development and availability of new imaging techniques such as CT and PET scans, peritoneal carcinomatosis can be diagnosed more easily and accurately. In our case the diagnosis was confirmed by a diagnostic laparoscopy with biopsy of the peritoneal nodules. The immunohistochemistry usually comprises CK5/6, TTF1, CK7 and CK20. In our case, the immunophynotype of CK7 positive, CK20 negative and TTF1 positive makes the primitive nature of the lung cancer almost certain [<xref rid="CIT0010" ref-type="bibr">10</xref>]. Despite recent medical and surgical advances, the treatment of peritoneal carcinomatosis is primarily palliative and the survival median is no more than two months [<xref rid="CIT0006" ref-type="bibr">6</xref>, <xref rid="CIT0007" ref-type="bibr">7</xref>].</p>
    </sec>
    <sec sec-type="conclusion" id="S0004">
      <title>Conclusion</title>
      <p>Peritoneal carcinomatosis from lung cancer remains a rare event. This diagnosis should always be considered for the occurrence of unexplained abdominal symptoms, especially in a patient already treated for lung cancer.</p>
    </sec>
  </body>
  <back>
    <sec id="S0005">
      <title>Competing interests</title>
      <p>The authors declare no competing interests.</p>
    </sec>
    <sec id="S0006">
      <title>Authors&#x2019; contributions</title>
      <p>The case report was written by Hanane Kloub. All authors have read and agreed to the final version of this manuscript and have equally contributed to its content and to the management of the case.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferlay</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Soerjomataram</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Dikshit</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Eser</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mathers</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rebelo</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012</article-title>
          <source>Int J Cancer J Int Cancer.</source>
          <year>2015</year>
          <season>Mars</season>
          <day>1</day>
          <volume>136</volume>
          <issue>5</issue>
          <fpage>E359</fpage>
          <lpage>86</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cellier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Daniel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kron</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Riquet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barbier</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Small bowel metastases from primary carcinoma of the lung: clinical findings and outcome</article-title>
          <source>Am J Gastroenterol.</source>
          <year>1999</year>
          <season>Juill</season>
          <volume>94</volume>
          <issue>7</issue>
          <fpage>1884</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">10406253</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mosier</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Bloch</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Dorman</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Small bowel metastases from primary lung carcinoma: a rarity waiting to be found?</article-title>
          <source>Am Surg.</source>
          <year>1992</year>
          <month>11</month>
          <volume>58</volume>
          <issue>11</issue>
          <fpage>677</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">1485699</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>C-J</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>J-J</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>W-Y</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>I-W</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>T-H</given-names>
            </name>
            <name>
              <surname>Sheu</surname>
              <given-names>C-C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gastro-intestinal metastasis of primary lung carcinoma: clinical presentations and outcome</article-title>
          <source>Lung Cancer Amst Neth.</source>
          <year>2006</year>
          <season>D&#xE9;c</season>
          <volume>54</volume>
          <issue>3</issue>
          <fpage>319</fpage>
          <lpage>23</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNeill</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Wagman</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Neifeld</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Small bowel metastases from primary carcinoma of the lung</article-title>
          <source>Cancer.</source>
          <year>1987</year>
          <season>Avr</season>
          <day>15</day>
          <volume>59</volume>
          <issue>8</issue>
          <fpage>1486</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">3028602</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Kurishima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohtsuka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sekizawa</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Peritoneal carcinomatosis in lung cancer patients</article-title>
          <source>Oncol Rep.</source>
          <year>2001</year>
          <season>D&#xE9;c</season>
          <volume>8</volume>
          <issue>6</issue>
          <fpage>1305</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">11605054</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Su</surname>
              <given-names>H-T</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>C-M</given-names>
            </name>
            <name>
              <surname>Perng</surname>
              <given-names>R-P</given-names>
            </name>
          </person-group>
          <article-title>Peritoneal carcinomatosis in lung cancer</article-title>
          <source>Respirol Carlton Vic.</source>
          <year>2008</year>
          <season>Mai</season>
          <volume>13</volume>
          <issue>3</issue>
          <fpage>465</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0008">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ba</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fondronnier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Michalski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gossot</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Savinelli</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>[Abdominal pain during the course of lung cancer]</article-title>
          <source>Rev Pneumol Clin.</source>
          <year>2007</year>
          <season>Avr</season>
          <volume>63</volume>
          <issue>2</issue>
          <fpage>100</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">17607214</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0009">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugarbaker</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy</article-title>
          <source>Cancer Treat Res.</source>
          <year>1996</year>
          <volume>81</volume>
          <fpage>149</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="pmid">8834582</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0010">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reis-Filho</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Carrilho</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Valenti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Leit&#xE3;o</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>SG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?</article-title>
          <source>Pathol Res Pract.</source>
          <year>2000</year>
          <volume>196</volume>
          <issue>12</issue>
          <fpage>835</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">11156325</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
